CPAY vs VRSN Stock Comparison 2026 | Alert Invest

CPAY
vs
VRSN
Updated 2026-05-14

Corpay, Inc. (CPAY) vs VeriSign, Inc. (VRSN): Stock Comparison 2026

Corpay, Inc. (CPAY) price$331.465
CPAY analyst target$373.86
VeriSign, Inc. (VRSN) price$296.055
VRSN analyst target$355
SectorTechnology

How this CPAY vs VRSN comparison is calculated

All metrics are based on trailing twelve months (TTM) financial data, consensus analyst estimates, and standardized valuation ratios. Data is sourced from Financial Modeling Prep and SEC EDGAR. Figures are normalized to ensure a fair comparison between Corpay, Inc. and VeriSign, Inc.. Analyst price targets and ratings are aggregated from Wall Street consensus as of 2026-05-14.

Quick verdict: Corpay, Inc. vs VeriSign, Inc. in 2026

Corpay, Inc. (CPAY) stands out as the growth leader, boasting a significantly higher revenue expansion rate and a more attractive earnings multiple. While VeriSign, Inc. (VRSN) showcases superior profitability margins and a higher analyst price target upside, CPAY presents a compelling fundamental discount and stronger free cash flow generation. Not investment advice.

Best for Growth: Corpay, Inc. (CPAY)
Best for Value: Corpay, Inc. (CPAY)
Best for Income: VeriSign, Inc. (VRSN)

Corpay, Inc. vs VeriSign, Inc.: key metrics side by side

A full side-by-side look at Corpay, Inc. (CPAY) and VeriSign, Inc. (VRSN) across earnings multiples, profitability, revenue momentum, and analyst sentiment — data updated 2026-05-14.

CPAY5 wins
vs
VRSN7 wins
MetricCPAYVRSN
Revenue (TTM)$4.53B$1.66B
Revenue growth YoY13.9% CPAY wins6.4%
Gross margin72.79%88.35% VRSN wins
Net margin24.60%49.96% VRSN wins
EBITDA margin51.91%70.34% VRSN wins
ROEN/A%N/A%
FCF yield6.05% CPAY wins3.89%
P/E ratio19.03x CPAY wins32.25x
P/B ratio6.38x-12.25x VRSN wins
Debt / equity2.95x-0.81x VRSN wins
Dividend yield0%0.01% VRSN wins
Buy rating %72.2% CPAY wins57.1%
Analyst consensusBuyBuy
Price target upside+12.8%+19.9% VRSN wins
DCF upside+111.4% CPAY wins-1.8%
FMP ratingA-B-
Overall edge: VRSN leads on 7 of 12 comparable metrics.

Relative valuation: CPAY vs VRSN

When evaluating the relative merits of Corpay, Inc. and VeriSign, Inc. from a valuation perspective, CPAY appears to trade at a more attractive earnings multiple. Corpay, Inc. stock is currently valued at a P/E ratio of 19.03x, which is significantly lower than VeriSign, Inc.’s earnings multiple of 32.25x. This substantial price-to-earnings gap suggests that investors are paying a premium for VRSN’s earnings compared to CPAY, based on current consensus data. Furthermore, looking at the Discounted Cash Flow (DCF) model, CPAY shows a remarkable potential upside of +111.4%, indicating that its intrinsic value could be considerably higher than its current market price of $331.465.

Conversely, VeriSign, Inc. presents a DCF model suggesting a slight overvaluation, with a downside of -1.8% from its current price of $296.055. While the price-to-book ratio for CPAY stands at 6.38x, VRSN exhibits an unusual negative P/B of -12.25x, which typically arises from negative shareholders’ equity, often due to aggressive share repurchases. This negative book value makes a direct comparison using this metric challenging. However, the pronounced fundamental discount in CPAY’s earnings multiple and robust DCF upside clearly positions Corpay, Inc. as the more attractively valued option between the two, assuming its growth and profitability can be sustained.

Revenue momentum: Corpay, Inc. vs VeriSign, Inc.

Examining the topline expansion, Corpay, Inc. demonstrates a more robust growth trajectory compared to VeriSign, Inc.. CPAY reported a year-over-year revenue growth of +13.9%, which significantly outpaces VRSN’s more modest +6.4% revenue increase. This suggests Corpay, Inc. is expanding its business operations and market share at a faster clip, indicative of stronger operational momentum. The difference in revenue growth percentages highlights a divergence in their recent performance, with CPAY showing a greater ability to scale its sales.

While VeriSign, Inc. showcases a superior EBITDA margin of 70.34% compared to Corpay, Inc.’s 51.91%, suggesting excellent operational efficiency and cost management within its existing revenue base, the raw revenue growth figures still point to CPAY as the one with stronger momentum. This gap in growth may not persist indefinitely if VRSN’s highly profitable operations allow for strategic investments that accelerate future sales. However, based on the most recent trailing twelve months data, Corpay, Inc. clearly exhibits the more dynamic expansion in its revenue generation, which could be a key factor for investors prioritizing growth potential and anticipating higher forward estimates.

Wall Street view: Corpay, Inc. vs VeriSign, Inc. analyst ratings

The sentiment from Wall Street analysts appears more bullish towards Corpay, Inc. than VeriSign, Inc., though both maintain a ‘Buy’ consensus. Corpay, Inc. has garnered analyst attention from 18 professionals, with a significant 72.2% issuing a ‘Buy’ rating. The collective price target for CPAY is set at $373.86, which represents an upside potential of +12.8% from its current price. This strong majority of buy ratings suggests a high degree of confidence in Corpay, Inc.’s future performance and strategic direction among the analyst community.

On the other hand, VeriSign, Inc. is covered by 14 analysts, with 57.1% recommending a ‘Buy’. While still a positive outlook, this percentage is notably lower than CPAY’s. The consensus target for VRSN stands at $355, implying an impressive +19.9% upside from its present valuation. Despite a lower percentage of ‘Buy’ ratings, VeriSign, Inc. offers a higher projected price target upside, suggesting that those analysts who are bullish see greater appreciation potential for VRSN. It is important to remember that analyst targets may vary depending on future estimate revisions and market conditions.

Which investor profile fits CPAY vs VRSN?

For the growth-oriented investor, Corpay, Inc. (CPAY) appears to be the more compelling choice. With a revenue growth rate of +13.9% year-over-year, CPAY significantly outpaces VeriSign, Inc.’s (VRSN) +6.4% expansion. This indicates a more dynamic business actively expanding its market presence and generating higher sales volume. Growth investors typically prioritize companies demonstrating robust topline momentum, and Corpay, Inc.’s current trajectory aligns well with this investment philosophy, suggesting stronger potential for future earnings increases.

Value investors, seeking companies trading below their intrinsic worth, might find Corpay, Inc. more appealing due to its more attractive earnings multiple and substantial DCF upside. CPAY trades at a P/E ratio of 19.03x, which is considerably lower than VRSN’s P/E of 32.25x, implying a relative discount for Corpay, Inc. stock. Furthermore, CPAY boasts a remarkable DCF upside of +111.4% (with an estimated fair value of $700.66), whereas VeriSign, Inc.’s DCF suggests a slight overvaluation with a -1.8% downside (fair value $290.86). This significant disparity in intrinsic value estimates positions CPAY as a strong candidate for those focused on acquiring assets at a bargain.

For income investors, the landscape is less distinct, as neither company offers a significant dividend yield. Corpay, Inc. currently has a 0% dividend yield, while VeriSign, Inc. offers a minuscule 0.01%. Therefore, neither CPAY nor VRSN would be a primary choice for investors seeking regular, substantial dividend income. Investors prioritizing income might need to look elsewhere in the market. This is not investment advice. Always do your own research.

Alert Invest · Free Newsletter

Get alerts when top investors buy a stock!

Track institutional moves and analyst changes for Corpay, Inc. and VeriSign, Inc.. Free, every week.

  • Institutional & insider moves
  • Analyst upgrades & downgrades
  • 100% free — unsubscribe anytime

Get free investor alerts →

For informational purposes only. Not investment advice. Data sourced from Financial Modeling Prep and SEC EDGAR. Always conduct your own research before making investment decisions.